These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 37285616

  • 21. Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
    Azukaitis K, Ju W, Kirchner M, Nair V, Smith M, Fang Z, Thurn-Valsassina D, Bayazit A, Niemirska A, Canpolat N, Bulut IK, Yalcinkaya F, Paripovic D, Harambat J, Cakar N, Alpay H, Lugani F, Mencarelli F, Civilibal M, Erdogan H, Gellermann J, Vidal E, Tabel Y, Gimpel C, Ertan P, Yavascan O, Melk A, Querfeld U, Wühl E, Kretzler M, Schaefer F, 4C Study, ESCAPE Trial Group.
    Kidney Int; 2019 Jul; 96(1):214-221. PubMed ID: 31005273
    [Abstract] [Full Text] [Related]

  • 22. Routinely measured iohexol glomerular filtration rate versus creatinine-based estimated glomerular filtration rate as predictors of mortality in patients with advanced chronic kidney disease: a Swedish Chronic Kidney Disease Registry cohort study.
    Methven S, Gasparini A, Carrero JJ, Caskey FJ, Evans M.
    Nephrol Dial Transplant; 2017 Apr 01; 32(suppl_2):ii170-ii179. PubMed ID: 28339801
    [Abstract] [Full Text] [Related]

  • 23. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Peralta CA, Katz R, Bonventre JV, Sabbisetti V, Siscovick D, Sarnak M, Shlipak MG.
    Am J Kidney Dis; 2012 Dec 01; 60(6):904-11. PubMed ID: 22749388
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Anderson AH, Xie D, Wang X, Baudier RL, Orlandi P, Appel LJ, Dember LM, He J, Kusek JW, Lash JP, Navaneethan SD, Ojo A, Rahman M, Roy J, Scialla JJ, Sondheimer JH, Steigerwalt SP, Wilson FP, Wolf M, Feldman HI, CRIC Study Investigators.
    Am J Kidney Dis; 2021 Jan 01; 77(1):56-73.e1. PubMed ID: 32866540
    [Abstract] [Full Text] [Related]

  • 27. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B, Fuhrer T, Zhang J, Darshi M, Van Espen B, Montemayor D, de Boer IH, Dobre M, Hsu CY, Kelly TN, Raj DS, Rao PS, Saraf SL, Scialla J, Waikar SS, Sharma K, Natarajan L, CRIC Study Investigators.
    Am J Kidney Dis; 2020 Oct 01; 76(4):511-520. PubMed ID: 32387023
    [Abstract] [Full Text] [Related]

  • 28. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhavsar NA, Köttgen A, Coresh J, Astor BC.
    Am J Kidney Dis; 2012 Aug 01; 60(2):233-40. PubMed ID: 22542304
    [Abstract] [Full Text] [Related]

  • 29. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
    Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M.
    Clin J Am Soc Nephrol; 2009 Feb 01; 4(2):337-44. PubMed ID: 19176795
    [Abstract] [Full Text] [Related]

  • 30. Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.
    Rodríguez-Ortiz ME, Pontillo C, Rodríguez M, Zürbig P, Mischak H, Ortiz A.
    Sci Rep; 2018 Oct 29; 8(1):15940. PubMed ID: 30374033
    [Abstract] [Full Text] [Related]

  • 31. The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation does not improve the underestimation of Glomerular Filtration Rate (GFR) in people with diabetes and preserved renal function.
    MacIsaac RJ, Ekinci EI, Premaratne E, Lu ZX, Seah JM, Li Y, Boston R, Ward GM, Jerums G.
    BMC Nephrol; 2015 Dec 03; 16():198. PubMed ID: 26630928
    [Abstract] [Full Text] [Related]

  • 32. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
    Meijer E, Boertien WE, Nauta FL, Bakker SJ, van Oeveren W, Rook M, van der Jagt EJ, van Goor H, Peters DJ, Navis G, de Jong PE, Gansevoort RT.
    Am J Kidney Dis; 2010 Nov 03; 56(5):883-95. PubMed ID: 20888104
    [Abstract] [Full Text] [Related]

  • 33. Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study.
    Satirapoj B, Pooluea P, Nata N, Supasyndh O.
    J Diabetes Complications; 2019 Sep 03; 33(9):675-681. PubMed ID: 31227289
    [Abstract] [Full Text] [Related]

  • 34. Urine Trefoil Factors as Prognostic Biomarkers in Chronic Kidney Disease.
    Yamanari T, Sugiyama H, Tanaka K, Morinaga H, Kitagawa M, Onishi A, Ogawa-Akiyama A, Kano Y, Mise K, Ohmoto Y, Shikata K, Wada J.
    Biomed Res Int; 2018 Sep 03; 2018():3024698. PubMed ID: 29850501
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E, Kim YS.
    Korean J Intern Med; 2016 Nov 03; 31(6):1120-1130. PubMed ID: 27017386
    [Abstract] [Full Text] [Related]

  • 36. Biomarkers of renal function, which and when?
    Wasung ME, Chawla LS, Madero M.
    Clin Chim Acta; 2015 Jan 01; 438():350-7. PubMed ID: 25195004
    [Abstract] [Full Text] [Related]

  • 37. Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.
    Zhang WR, Craven TE, Malhotra R, Cheung AK, Chonchol M, Drawz P, Sarnak MJ, Parikh CR, Shlipak MG, Ix JH, SPRINT Research Group.
    Ann Intern Med; 2018 Nov 06; 169(9):610-618. PubMed ID: 30357395
    [Abstract] [Full Text] [Related]

  • 38. Plasma Neutrophil Gelatinase-Associated Lipocalin Associates with New-Onset Chronic Kidney Disease in the General Population.
    Bourgonje AR, Abdulle AE, Bourgonje MF, Kieneker LM, la Bastide-van Gemert S, Gordijn SJ, Hidden C, Nilsen T, Gansevoort RT, Mulder DJ, Dullaart RPF, de Borst MH, Bakker SJL, van Goor H.
    Biomolecules; 2023 Feb 09; 13(2):. PubMed ID: 36830706
    [Abstract] [Full Text] [Related]

  • 39. Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.
    Gutiérrez OM, Shlipak MG, Katz R, Waikar SS, Greenberg JH, Schrauben SJ, Coca S, Parikh CR, Vasan RS, Feldman HI, Kimmel PL, Cushman M, Bonventre JV, Sarnak MJ, Ix JH.
    Am J Kidney Dis; 2022 Jun 09; 79(6):849-857.e1. PubMed ID: 34752914
    [Abstract] [Full Text] [Related]

  • 40. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.
    Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, Safford MM, Zhang X, Muntner P, Warnock D.
    JAMA; 2011 Apr 20; 305(15):1545-52. PubMed ID: 21482744
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.